Mast cell activation machinery

Mast cell activation machinery refers to the integrated network of receptors, signaling proteins, and effector mechanisms that trigger the release of inflammatory mediators from mast cells. The primary driver is the high-affinity IgE receptor (FcεRI), which, upon cross-linking by allergen-bound IgE, initiates a phosphorylation cascade involving kinases like Lyn, Syk, and BTK (Galli et al., Nature, 2008). This process leads to degranulation, releasing pre-formed mediators like histamine and proteases, and the de novo synthesis of lipid mediators and cytokines (Metcalfe et al., Physiological Reviews, 1997). Other pathways, such as the MRGPRX2 receptor or the KIT receptor tyrosine kinase, also contribute to activation or modulation of mast cell sensitivity (Gilfillan & Rivera, Nature Reviews Immunology, 2009). Dysregulation of this machinery is central to allergic diseases, mastocytosis, and chronic inflammation (Theoharides et al., New England Journal of Medicine, 2015). Therapeutic strategies often focus on stabilizing the mast cell membrane or inhibiting specific signaling nodes within this complex machinery to prevent the systemic effects of mast cell-derived mediators.

Other names

Mast cell signaling pathwayMast cell degranulation pathwayFcεRI signaling complexMast cell activation cascade

Inhibition of IgE-FcεRI interaction, stabilization of mast cell membranes to prevent mediator release, and inhibition of intracellular signaling kinases such as Syk and KIT.